Select Page

News

UA Clinical Trial to Repurpose Ketamine for Parkinson’s Patients

(July 23, 2018) – University of Arizona researchers will repurpose ketamine, a drug currently used to treat pain and depression, to try to reduce and control dyskinesia, uncontrollable and involuntary movements of the arms, legs, head or entire body. brought on by levodopa. Read more

The Parkinson Alliance is a nonprofit, tax-exempt charitable organization under section 501(c)(3) of the Internal Revenue Code. Donations are tax-deductible as allowed by law. Copyright © 2024 The Parkinson Alliance. All rights reserved.